Get the Full Story, Without the Noise.
Published loading...Updated

ADC Therapeutics SA (NYSE:ADCT) Stock Position Boosted by Deutsche Bank AG

Summary by defenseworld.net
Deutsche Bank AG increased its stake in ADC Therapeutics SA (NYSE:ADCT – Free Report) by 40.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,062 shares of the company’s stock after acquiring an additional 16,217 shares during the period. Deutsche Bank AG owned approximately 0.06% of ADC Therapeutics worth $112,000 at the end of the most rece…

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Wednesday, June 4, 2025.
Sources are mostly out of (0)